Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin-bound paclitaxel maintenance vs best supportive care in advanced lung squamous cell carcinoma
ChiCTR2000034444Phase 4Not yet recruiting
- Sponsor
- Yunnan Cancer Hospital
- Start
- Jul 2020
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial in Pulmonary squamous cell carcinoma comparing Albumin-bound paclitaxel maintenance with Best supportive care (2 arms). Primary endpoint: Progression-free survival. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
nab-paclitaxel
03
Conditions
Pulmonary squamous cell carcinoma
Beyond the preview
Go deeper on ChiCTR2000034444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034444.